356 related articles for article (PubMed ID: 36960185)
21. Inhibition of prostate cancer osteoblastic progression with VEGF121/rGel, a single agent targeting osteoblasts, osteoclasts, and tumor neovasculature.
Mohamedali KA; Li ZG; Starbuck MW; Wan X; Yang J; Kim S; Zhang W; Rosenblum MG; Navone NM
Clin Cancer Res; 2011 Apr; 17(8):2328-38. PubMed ID: 21343372
[TBL] [Abstract][Full Text] [Related]
22. Subgroups of Castration-resistant Prostate Cancer Bone Metastases Defined Through an Inverse Relationship Between Androgen Receptor Activity and Immune Response.
Ylitalo EB; Thysell E; Jernberg E; Lundholm M; Crnalic S; Egevad L; Stattin P; Widmark A; Bergh A; Wikström P
Eur Urol; 2017 May; 71(5):776-787. PubMed ID: 27497761
[TBL] [Abstract][Full Text] [Related]
23. Prognostic factors for overall survival in prostate cancer patients with different site-specific visceral metastases: A study of 1358 patients.
Cui PF; Cong XF; Gao F; Yin JX; Niu ZR; Zhao SC; Liu ZL
World J Clin Cases; 2020 Jan; 8(1):54-67. PubMed ID: 31970170
[TBL] [Abstract][Full Text] [Related]
24. Real-world patient-reported outcomes of breast cancer or prostate cancer patients receiving antiresorptive therapy for bone metastases: Final results of the PROBone registry study.
Jakob A; Zahn MO; Nusch A; Werner T; Schnell R; Frank M; Hamm N; Däßler KU; Losem C; Welslau M; Hoevel P; Potthoff K
J Bone Oncol; 2022 Apr; 33():100420. PubMed ID: 35340302
[TBL] [Abstract][Full Text] [Related]
25. [Physiopathology and new therapeutic strategies in the management of bone metastases of prostate cancer].
Lebret T; Méjean A; Houédé N
Prog Urol; 2011 May; 21(5):301-7. PubMed ID: 21514531
[TBL] [Abstract][Full Text] [Related]
26. Bone Health Management in the Continuum of Prostate Cancer Disease.
Boopathi E; Birbe R; Shoyele SA; Den RB; Thangavel C
Cancers (Basel); 2022 Sep; 14(17):. PubMed ID: 36077840
[TBL] [Abstract][Full Text] [Related]
27. Bibliometric analysis of the global research development of bone metastases in prostate cancer: A 22-year study.
Chen Y; Tang C; Shen Z; Peng S; Wu W; Lei Z; Zhou J; Li L; Lai Y; Huang H; Guo Z
Front Oncol; 2022; 12():947445. PubMed ID: 36237319
[TBL] [Abstract][Full Text] [Related]
28. New radiopharmaceutical agents for the treatment of castration-resistant prostate cancer.
Maffioli L; Florimonte L; Costa DC; Correia Castanheira J; Grana C; Luster M; Bodei L; Chinol M
Q J Nucl Med Mol Imaging; 2015 Dec; 59(4):420-38. PubMed ID: 26222274
[TBL] [Abstract][Full Text] [Related]
29. Role of Neutrophil to Lymphocyte Ratio or Platelet to Lymphocyte Ratio in Prediction of Bone Metastasis of Prostate Cancer.
Zhang JY; Ge P; Zhang PY; Zhao M; Ren L
Clin Lab; 2019 May; 65(5):. PubMed ID: 31115239
[TBL] [Abstract][Full Text] [Related]
30. Survival with Newly Diagnosed Metastatic Prostate Cancer in the "Docetaxel Era": Data from 917 Patients in the Control Arm of the STAMPEDE Trial (MRC PR08, CRUK/06/019).
James ND; Spears MR; Clarke NW; Dearnaley DP; De Bono JS; Gale J; Hetherington J; Hoskin PJ; Jones RJ; Laing R; Lester JF; McLaren D; Parker CC; Parmar MKB; Ritchie AWS; Russell JM; Strebel RT; Thalmann GN; Mason MD; Sydes MR
Eur Urol; 2015 Jun; 67(6):1028-1038. PubMed ID: 25301760
[TBL] [Abstract][Full Text] [Related]
31. Molecular pathogenesis of bone metastases in breast cancer: Proven and emerging therapeutic targets.
Rucci N; Sanità P; Delle Monache S; Alesse E; Angelucci A
World J Clin Oncol; 2014 Aug; 5(3):335-47. PubMed ID: 25114849
[TBL] [Abstract][Full Text] [Related]
32. Prostate-specific Membrane Antigen Biology in Lethal Prostate Cancer and its Therapeutic Implications.
Sheehan B; Guo C; Neeb A; Paschalis A; Sandhu S; de Bono JS
Eur Urol Focus; 2022 Sep; 8(5):1157-1168. PubMed ID: 34167925
[TBL] [Abstract][Full Text] [Related]
33. Integrating the immune microenvironment of prostate cancer induced bone disease.
Ihle CL; Owens P
Mol Carcinog; 2020 Jul; 59(7):822-829. PubMed ID: 32233011
[TBL] [Abstract][Full Text] [Related]
34. Protease-activated receptor-2 dependent and independent responses of bone cells to prostate cancer cell secretory products.
Pagel CN; Kularathna PK; Sanaei R; Young ND; Hooper JD; Mackie EJ
Prostate; 2022 May; 82(6):723-739. PubMed ID: 35167724
[TBL] [Abstract][Full Text] [Related]
35. Up-regulation of MDA-BF-1, a secreted isoform of ErbB3, in metastatic prostate cancer cells and activated osteoblasts in bone marrow.
Vakar-Lopez F; Cheng CJ; Kim J; Shi GG; Troncoso P; Tu SM; Yu-Lee LY; Lin SH
J Pathol; 2004 Jun; 203(2):688-95. PubMed ID: 15141384
[TBL] [Abstract][Full Text] [Related]
36. Identification and validation of a novel overall survival prediction model for immune-related genes in bone metastases of prostate cancer.
Bi W; Guo W; Fan G; Xie L; Jiang C
Aging (Albany NY); 2023 Jul; 15(14):7161-7186. PubMed ID: 37494663
[TBL] [Abstract][Full Text] [Related]
37. Targeted Agents in Preclinical and Early Clinical Development for the Treatment of Cancer Bone Metastases.
Hiraga T
Expert Opin Investig Drugs; 2016; 25(3):319-34. PubMed ID: 26778342
[TBL] [Abstract][Full Text] [Related]
38. Prognostic factors influencing prostate cancer-specific survival in non-castrate patients with metastatic prostate cancer.
Ost P; Decaestecker K; Lambert B; Fonteyne V; Delrue L; Lumen N; Ameye F; De Meerleer G
Prostate; 2014 Feb; 74(3):297-305. PubMed ID: 24395565
[TBL] [Abstract][Full Text] [Related]
39. Prostate cancer bone metastases on staging prostate MRI: prevalence and clinical features associated with their diagnosis.
Vargas HA; Schor-Bardach R; Long N; Kirzner AN; Cunningham JD; Goldman DA; Moskowitz CS; Sosa RE; Sala E; Panicek DM; Hricak H
Abdom Radiol (NY); 2017 Jan; 42(1):271-277. PubMed ID: 27480976
[TBL] [Abstract][Full Text] [Related]
40. CXCR4 pharmacogical inhibition reduces bone and soft tissue metastatic burden by affecting tumor growth and tumorigenic potential in prostate cancer preclinical models.
Gravina GL; Mancini A; Muzi P; Ventura L; Biordi L; Ricevuto E; Pompili S; Mattei C; Di Cesare E; Jannini EA; Festuccia C
Prostate; 2015 Sep; 75(12):1227-46. PubMed ID: 26073897
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
